-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Ionis Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Ionis Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$149M, a 3.76% decline year-over-year.
- Ionis Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$370M, a 33.3% increase year-over-year.
- Ionis Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$354M, a 13.8% increase from 2022.
- Ionis Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$410M, a 1259% decline from 2021.
- Ionis Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$30.2M, a 82.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)